QI
RMD icon

QS Investors’s ResMed RMD Stock Holding History

QS Investors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$1.22M Buy
4,957
+388
+8% +$81.6K 0.01% 442
2021
Q1 		$887K Sell
4,569
-400
-8% -$80.2K 0.01% 572
2020
Q4 		$1.06M Buy
4,969
+236
+5% +$47.1K 0.01% 484
2020
Q3 		$812K Sell
4,733
-422
-8% -$77.9K 0.01% 517
2020
Q2 		$990K Sell
5,155
-600
-10% -$98.2K 0.01% 726
2020
Q1 		$848K Sell
5,755
-5,876
-51% -$936K 0.01% 709
2019
Q4 		$1.82M Buy
11,631
+68
+0.6% +$9.8K 0.02% 617
2019
Q3 		$1.56M Hold
11,563
– – 0.02% 644
2019
Q2 		$1.41M Hold
11,563
– – 0.02% 698
2019
Q1 		$1.2M Sell
11,563
-28,156
-71% -$2.91M 0.01% 760
2018
Q4 		$4.52M Buy
39,719
+20,357
+105% +$2.18M 0.06% 245
2018
Q3 		$2.23M Buy
19,362
+10,684
+123% +$1.17M 0.02% 587
2018
Q2 		$899K Hold
8,678
– – 0.01% 808
2018
Q1 		$855K Hold
8,678
– – 0.01% 817
2017
Q4 		$735K Buy
8,678
+171
+2% +$14.1K 0.01% 857
2017
Q3 		$655K Buy
8,507
+1,710
+25% +$131K 0.01% 889
2017
Q2 		$529K Hold
6,797
– – ﹤0.01% 917
2017
Q1 		$489K Buy
6,797
+4,900
+258% +$339K ﹤0.01% 974
2016
Q4 		$118K Sell
1,897
-30,700
-94% -$1.88M ﹤0.01% 1245
2016
Q3 		$2.11M Sell
32,597
-12,764
-28% -$850K 0.02% 635
2016
Q2 		$2.87M Sell
45,361
-76,663
-63% -$4.52M 0.02% 553
2016
Q1 		$7.05M Buy
122,024
+122,013
+1,109,209% +$6.91M 0.07% 289
2015
Q4 		$1K Buy
+11
New +$620 ﹤0.01% 1776
2014
Q3 		– Sell
-200
Closed -$10K – 784
2014
Q2 		$10K Buy
+200
New +$9.91K ﹤0.01% 771
2013
Q4 		– Sell
-62,700
Closed -$3.31M – 619
2013
Q3 		$3.31M Buy
62,700
+56,300
+880% +$2.73M 0.14% 156
2013
Q2 		$289K Buy
+6,400
New +$304K 0.01% 588

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

QS Investors's RMD Position: Q2 2021 in Review

QS Investors increased its ResMed (RMD) stake by 8.5% in Q2 2021, buying an estimated $81.6K and bringing the position to 4,957 shares worth $1.22M. The position accounts for 0.01% of the portfolio, ranked #442.

QS Investors first reported a position in RMD in Q2 2013 and has held it in 26 quarters since. The position peaked at $7.05M in Q1 2016. 661 funds tracked by Wall St. Rank hold RMD as of Q2 2021.

  • QS Investors held 4,957 shares of ResMed worth $1.22M as of Q2 2021.
  • QS Investors bought 388 ResMed shares in Q2 2021, an estimated $81.6K.
  • ResMed made up 0.01% of QS Investors's portfolio in Q2 2021, its #442 holding.
  • QS Investors first reported a position in ResMed in Q2 2013 and has held it in 26 quarters since.
  • QS Investors's ResMed position peaked at $7.05M in Q1 2016.
  • 661 funds tracked by Wall St. Rank held ResMed as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.